Upon comparing RRMS and SPMS patients, both the serum and CSF IGFBP7 levels were markedly elevated in SPMS patients compared to RRMS patients (P=0.011 and P=0.026, respectively; Figure 5A). This evidence concerns the gene IGFBP7 and secondary progressive multiple sclerosis.